life sciences
14 articles about life sciences in AI news
OpenAI Launches GPT-Rosalind for Drug Discovery, GPT-5.4-Cyber for Security
OpenAI launched GPT-Rosalind, a life sciences model performing above the 95th percentile of human experts on novel biological data, and GPT-5.4-Cyber, a cybersecurity variant. These releases, alongside a major Agents SDK update, signal a pivot from general AI to specialized, high-stakes enterprise domains.
Boston Consulting Group on 'Speaking Your AI Agent’s Language'
BCG highlights the critical need for effective human-AI agent communication as a cornerstone of digital transformation, particularly in complex, regulated industries like life sciences. This principle is broadly applicable to retail.
From Bota to Enhe: The Dawn of Physical AI in Biomanufacturing
Bota Bio has rebranded as Enhe Technology and launched SAION AI, a pioneering Physical AI platform for biomanufacturing. The platform claims state-of-the-art performance across four key life science AI benchmarks, signaling a major shift in how biology is engineered.
Anthropic Launches Claude Science as New Flagship
Anthropic launched Claude Science as a new flagship for computational biology and Claude Sonnet 5 with a stealth 30% effective price increase via a new tokenizer.
Anthropic Launches Claude Tag as Multiplayer Slack Agent Ahead of IPO
Anthropic released Claude Tag, a Slack-native agent for teams. The tool already approves 65% of internal code changes as Anthropic pushes enterprise adoption ahead of its 2026 IPO.
AI-Driven Age-Reversal Therapy Enters First Human Trials
An AI-discovered therapeutic approach for biological age reversal has advanced to its first human trials. This milestone validates the use of AI for identifying novel geroprotective compounds.
AI Firms Target Biotech for High-Impact, High-Margin Applications
A trend analysis notes AI companies are shifting focus to biotech, where accurate prediction models can be monetized through drug discovery and synthetic biology, creating a new competitive frontier.
DrugPlayGround Benchmark Tests LLMs on Drug Discovery Tasks
A new framework called DrugPlayGround provides the first standardized benchmark for evaluating large language models on key drug discovery tasks, including predicting drug-protein interactions and chemical properties. This addresses a critical gap in objectively assessing LLMs' potential to accelerate pharmaceutical research.
Anthropic Acquires AI Biotech Coefficient Bio for ~$400M to Build 'Virtual Biologist'
Anthropic acquired AI biotech startup Coefficient Bio for approximately $400M. The small team was building AI to plan drug R&D, manage clinical strategy, and identify new drug opportunities, aligning with CEO Dario Amodei's vision of AI as a 'virtual biologist.'
BloClaw: New AI4S 'Operating System' Cuts Agent Tool-Calling Errors to 0.2% with XML-Regex Protocol
Researchers introduced BloClaw, a unified operating system for AI-driven scientific discovery that replaces fragile JSON tool-calling with a dual-track XML-Regex protocol, cutting error rates from 17.6% to 0.2%. The system autonomously captures dynamic visualizations and provides a morphing UI, benchmarked across cheminformatics, protein folding, and molecular docking.
Palantir and NVIDIA Forge Strategic Alliance to Power Next-Generation AI Platforms
Palantir Technologies and NVIDIA have announced a major collaboration to develop enterprise AI platforms. The partnership aims to integrate Palantir's data analytics with NVIDIA's accelerated computing to deliver powerful AI solutions for government and commercial sectors.
The AI-Powered 'Cocktail': How One Injection Could Revolutionize Healthcare by 2029
A leading AI researcher predicts that within five years, personalized medical treatments delivered via single injections or pills will become reality. This breakthrough promises to democratize access to advanced healthcare through AI-driven drug discovery and delivery systems.
China's Nuclear Revolution: How Particle Accelerators Could Power Civilization for a Millennium
Chinese scientists are developing an accelerator-driven subcritical reactor that burns nuclear waste as fuel, potentially providing clean energy for 1,000 years while solving radioactive waste problems. The megawatt-scale prototype aims for 2027 operation.
AI Reimagines Public Transit: New Framework Tackles the Core Problem of Uncertain Demand
Researchers have developed a novel AI-powered framework, 2LRC-TND, that uses machine learning and contextual stochastic optimization to design public transit networks by modeling two layers of uncertain rider demand. This moves beyond traditional fixed-demand models to create more resilient and effective transportation systems.